{"public_id":"co_261600116dddd708f9f49aaf068661ab","status":"active","merged_into_public_id":null,"resolved_public_id":"co_261600116dddd708f9f49aaf068661ab","name":"rituximab","description":"A monoclonal antibody used as an immunotherapy for neuromyelitis optica.","aliases":[],"types":["drug","biological therapy"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":1215691,"title":"Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)","citation_count":568,"url":"https://sah.borca.ai/papers/1215691"}],"claims":[{"public_id":"cl_2cc2e0614b45ed5cdb450e70d32af29d","text":"Rituximab is increasingly regarded as an established therapy with long-term efficacy and an acceptable safety profile in neuromyelitis optica patients.","corpus_id":1215691,"url":"https://sah.borca.ai/claims/cl_2cc2e0614b45ed5cdb450e70d32af29d"},{"public_id":"cl_7e0d7e49fba033332de51522b57b39ee","text":"Early initiation of therapy is recommended, with azathioprine and rituximab suggested as first-line treatments and methotrexate, mycophenolate mofetil, and mitoxantrone recommended as second-line treatments.","corpus_id":1215691,"url":"https://sah.borca.ai/claims/cl_7e0d7e49fba033332de51522b57b39ee"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_261600116dddd708f9f49aaf068661ab","url":"https://sah.borca.ai/concepts/co_261600116dddd708f9f49aaf068661ab"}